Roche’s Fenebrutinib Faces Regulatory Scrutiny Despite Landmark FDA Application Acceptance for Multiple Sclerosis.
admin The U.S. Food and Drug Administration (FDA) has accepted Roche’s application for fenebrutinib, a Bruton’s...
biotech
Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
Bristol Myers Squibb (BMS) has confirmed that its investigational drug, admilparant, an LPA1 receptor inhibitor,...
Advancing Immunotherapy for Childhood Cancers: Unraveling Unique Biologies and Pioneering New Paths
September marks Childhood Cancer Awareness Month, a crucial period dedicated to illuminating the persistent challenges...
Advancing Immunotherapy for Childhood Cancers: A New Era of Targeted Treatment
By Robbie Majzner, MD, Contributing Author Despite remarkable strides in pediatric oncology over the past...
Unveiling the Fertility Landscape After CAR T-Cell Therapy: A Critical Inquiry for Cancer Survivors
The long-term quality of life for cancer survivors, particularly younger patients, is increasingly coming into...
Beam Therapeutics Files Landmark Trade Secret Lawsuit Against YolTech and Serapha Bio Over Alleged IP Theft in Gene Editing.
In a high-stakes legal battle poised to send ripples across the burgeoning gene editing industry,...
Pioneering Immunologist Alexander Rudensky Celebrated at Milestone Symposium on Immunity, Inflammation, and Tolerance
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, transcended the...
AstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push
London, UK & Cambridge, MA – In a significant move set to reshape a segment...
Cancer Research Institute Defies Uncertainty with Record $34.4 Million in Grants, Propelling Innovation in Immunotherapy
In a fiscal year marked by significant headwinds for scientific research, the Cancer Research Institute...
Honoring a Legacy: The Victoria Ann Michelis Fund Propels Innovative Ovarian Cancer Research and Philanthropy
Rob Malone, a contributing author and close friend, is channeling the indomitable spirit and profound...
